Morgan Ebert, Managing Editor

A meta-analysis presented at 2025 ACOG Annual Clinical & Scientific Meeting found that elinzanetant demonstrated a reduction in VMS frequency and intensity.

Shared decision making and individualized strategies are emphasized in the new ACOG consensus.

A quick look into some of the top sessions occurring at the 2025 ACOG Annual Clinical and Scientific Meeting, being held from May 16-18, 2025, in Minneapolis, Minnesota.

Take a quick look at everything you may have missed last month, including the latest FDA updates, top stories, and exclusive interviews.

New guidelines on GSM recommends symptom-based diagnosis, shared decision-making, and local estrogen as first-line therapy to improve quality of life.

A UK study links maternal anemia in early pregnancy with increased congenital heart disease risk in offspring.

Find out the top 5 latest updates and headlines in fertility research in honor of National Infertility Awareness Week (April 20-26, 2025).

A new survey highlights gender differences in knowledge and attitudes toward GLP-1/GIP receptor agonists.

A novel oral antibiotic, gepotidacin (Blujepa; GSK), has demonstrated its effectiveness in treating uncomplicated urogenital gonorrhea, according to the results of a recent phase 3 clinical trial.

A recent study found IL-6 may help with earlier sepsis detection in pregnant women, children, and newborns, outperforming traditional diagnostic tests.

Two-thirds of US teen girls live in states with abortion bans, gestational limits, or parental involvement laws, limiting access to care.

Women with prior pre-eclampsia develop cardiovascular (CV) risk factors nearly a decade earlier, prompting calls for earlier and regular CV screening.

Primary care interventions, such as education and support, effectively promote breastfeeding up to 6 months, improving rates of any and exclusive breastfeeding, according to the USPSTF.

Take a quick look at everything you may have missed during Q1 of 2025, including the latest FDA approvals, top stories, and exclusive interviews.

Pregnancy may lower Long COVID risk, with researchers linking immune changes to reduced symptoms, though some groups remain vulnerable.

Experts release first clinical guidance on polygenic risk scores for breast cancer, outlining integration into screening and prevention strategies.

Check out the top conferences happening in the second quarter of 2025.

The study is among the first to examine dietary patterns relating to overall healthy aging rather than specific diseases or mortality.

Ryan Haumschild, PharmD, MS, MBA, CPEL, explains the impact recently FDA-approved gepotidacin will have on uncomplicated UTIs and what this means in terms of antibiotic stewardship.

A nurse-led intervention increased HPV vaccination rates among Hispanic adolescents in a rural North Carolina clinic, according to research presented at the 2025 NAPNAP conference.

A recent study from researchers at the University of Calgary found that a higher frequency of menopausal symptoms i linked to poorer cognitive function and behavioral impairments

Sexual inactivity worsens SSRI side effects in women, but gepirone-ER shows fewer impacts.

A new study presented at ISSWSH highlights patient dissatisfaction with current treatments for recurrent bacterial vaginosis, emphasizing the need for more effective therapies and improved provider communication.

While pain is a common deterrent for patients considering an IUD, there are no standardized guidelines for pain relief during insertion or removal.

Many women experience perimenopause symptoms in their 30s, but most delay treatment. Early awareness can improve care and quality of life.

A study finds that esketamine during cesarean delivery may reduce postpartum depression risk, though further research is needed to confirm its safety and efficacy.

A survey by Aeroflow Urology finds many mothers face postpartum incontinence without medical support, impacting their health, stress, and daily life.

BlueWind Medical’s Revi System shows strong two-year efficacy and safety for UUI, with symptom reduction and high patient satisfaction.

Nicola F. Tavella, MPH, dives into his team's research on postpartum depression and unplanned cesarean delivery, which was presented at SMFM's 2025 Pregnancy Meeting.

A new study links first-trimester hemorrhage and anemia to a higher placenta accreta spectrum risk, emphasizing early screening and non-traditional risk factors.